Cite
HARVARD Citation
Seidlitz, T. et al. (2022). Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer. EMBO molecular medicine. 14 (10), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Seidlitz, T. et al. (2022). Sensitivity towards HDAC inhibition is associated with RTK/MAPK pathway activation in gastric cancer. EMBO molecular medicine. 14 (10), p. n/a. [Online].